These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 8172793)
1. Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: treatment results and prognostic factor analysis in a multi-centre trial. Köppler H; Pflüger KH; Eschenbach I; Pfab R; Birkmann J; Zeller W; Holle R; Steinhauer UE; Gropp C; Oehl S Ann Oncol; 1994 Jan; 5(1):49-55. PubMed ID: 8172793 [TBL] [Abstract][Full Text] [Related]
2. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Wunderlich A; Kloess M; Reiser M; Rudolph C; Truemper L; Bittner S; Schmalenberg H; Schmits R; Pfreundschuh M; Loeffler M; Ann Oncol; 2003 Jun; 14(6):881-93. PubMed ID: 12796026 [TBL] [Abstract][Full Text] [Related]
3. Sequential versus alternating chemotherapy for high grade non-Hodgkin's lymphomas: a randomized multicentre trial. Köppler H; Pflüger KH; Eschenbach I; Pfab R; Birkmann J; Zeller W; Steinhauer EU; Gropp C; Oehl S; Lötzke E Hematol Oncol; 1991; 9(4-5):217-23. PubMed ID: 1743624 [TBL] [Abstract][Full Text] [Related]
4. Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial. Köppler H; Pflüger KH; Eschenbach I; Pfab R; Bruntsch U; Zeller W; Steinhauer EU; Gropp C; Oehl S; Lötzke E Onkologie; 1990 Feb; 13(1):28-32. PubMed ID: 2186321 [TBL] [Abstract][Full Text] [Related]
5. Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate- and high-grade non-Hodgkin's lymphomas. Novantrone International Study Group. Bezwoda W; Rastogi RB; Erazo Valla A; Diaz-Maqueo JC; Pavlovsky S; Morioka H; Resegotti L; Rueckle H; Somoza N; Moreno-Nogueira JA Eur J Cancer; 1995 Jun; 31A(6):903-11. PubMed ID: 7646919 [TBL] [Abstract][Full Text] [Related]
6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Boehme V; Zeynalova S; Kloess M; Loeffler M; Kaiser U; Pfreundschuh M; Schmitz N Ann Oncol; 2007 Jan; 18(1):149-157. PubMed ID: 17018708 [TBL] [Abstract][Full Text] [Related]
8. Multicentre combined chemotherapy protocol for large cell advanced non Hodgkin's lymphoma. Dumont J; Charpy-Validire P; Mosseri V; Gabarre J; Belanger C; Turpin F; Binet JL; Dreyfus F; Fourquet A; Janvier M Hematol Oncol; 1991; 9(4-5):197-207. PubMed ID: 1720759 [TBL] [Abstract][Full Text] [Related]
9. Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. Itoh K; Ohtsu T; Fukuda H; Sasaki Y; Ogura M; Morishima Y; Chou T; Aikawa K; Uike N; Mizorogi F; Ohno T; Ikeda S; Sai T; Taniwaki M; Kawano F; Niimi M; Hotta T; Shimoyama M; Tobinai K; Ann Oncol; 2002 Sep; 13(9):1347-55. PubMed ID: 12196359 [TBL] [Abstract][Full Text] [Related]
10. Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP. Economopoulos T; Dimopoulos MA; Mellou S; Pavlidis N; Samantas E; Nicolaides C; Tsatalas C; Papadopoulos A; Papageogriou E; Papasavvas P; Fountzilas G Eur J Haematol; 2002 Mar; 68(3):135-43. PubMed ID: 12068793 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma. Wöhrer S; Chott A; Drach J; Püspök A; Hejna M; Hoffmann M; Raderer M Ann Oncol; 2004 Nov; 15(11):1680-3. PubMed ID: 15520071 [TBL] [Abstract][Full Text] [Related]
12. Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin's lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Pfreundschuh M; Zwick C; Zeynalova S; Dührsen U; Pflüger KH; Vrieling T; Mesters R; Mergenthaler HG; Einsele H; Bentz M; Lengfelder E; Trümper L; Rübe C; Schmitz N; Loeffler M; Ann Oncol; 2008 Mar; 19(3):545-52. PubMed ID: 18065407 [TBL] [Abstract][Full Text] [Related]
13. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas. Tondini C; Zanini M; Lombardi F; Bengala C; Rocca A; Giardini R; Buzzoni R; Valagussa P; Bonadonna G J Clin Oncol; 1993 Apr; 11(4):720-5. PubMed ID: 8478665 [TBL] [Abstract][Full Text] [Related]
14. A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi. Baldini L; Guffanti A; Gobbi P; Colombi M; Federico M; Avanzini P; Cavanna L; Pieresca C; Silingardi V; Maiolo AT Cancer; 1997 Mar; 79(6):1234-40. PubMed ID: 9070503 [TBL] [Abstract][Full Text] [Related]
15. Vincristine, doxorubicin, cyclophosphamide, prednisone and etoposide (VACPE) in high-grade non-Hodgkin's lymphoma--a multicenter phase II study. Bergmann L; Karakas T; Lautenschlager G; Jager E; Knuth A; Mitrou PS; Hoelzer D Ann Oncol; 1995 Dec; 6(10):1019-24. PubMed ID: 8750155 [TBL] [Abstract][Full Text] [Related]
16. CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group. Cameron DA; White JM; Proctor SJ; Prescott RJ; Leonard RC; Angus B; Cook MK; Dawes PJ; Dawson AA; Evans RG; Galloway MJ; Harris AL; Heppleston A; Horne CH; Krajewski AS; Lennard AL; Lessells AM; Lucraft HH; MacGillivray JB; Mackie MJ; Parker AC; Roberts JT; Taylor PR; Thompson WD Eur J Cancer; 1997 Jul; 33(8):1195-201. PubMed ID: 9301442 [TBL] [Abstract][Full Text] [Related]
17. Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study. Späth-Schwalbe E; Lange C; Genvresse I; Krüger L; Eucker J; Schweigert M; Sezer O; Budach V; Possinger K Anticancer Drugs; 2002 Apr; 13(4):395-403. PubMed ID: 11984085 [TBL] [Abstract][Full Text] [Related]
18. A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphoma. Bessell EM; Burton A; Haynes AP; Glaholm J; Child JA; Cullen MH; Davies JM; Smith GM; Ellis IO; Jack A; Jones EL; Ann Oncol; 2003 Feb; 14(2):258-67. PubMed ID: 12562653 [TBL] [Abstract][Full Text] [Related]
19. VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin's lymphoma: a retrospective analysis of 45 patients. Singer JM; Mijovic A; Pettingale KW; Nethersell A; Dobbs HJ; Samaratunga IR; Lakhani A; Mufti GJ Clin Oncol (R Coll Radiol); 1995; 7(6):366-70. PubMed ID: 8590697 [TBL] [Abstract][Full Text] [Related]
20. CHOP with high dose cyclophosphamide consolidation versus CHOP alone as initial therapy for advanced stage, indolent non-Hodgkin's lymphomas. Pan D; Qin J; Farber C; O'Brien J; Filippa D; Portlock CS Leuk Lymphoma; 2003 Jun; 44(6):967-71. PubMed ID: 12854895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]